Business Wire12d
PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations
PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies* (NASDAQ: IINN) ...
Inspira Technologies’ HYLA blood sensor achieves 96% accuracy
Inspira Technologies (IINN) announced positive results from the clinical study of its AI-powered HYLA blood sensor. The HYLA achieved 96% ...
Inspira announces positive results from clinical study of HYLA blood sensor, achieving 96% accuracy
Inspira Technologies' HYLA blood sensor achieves 96% accuracy in clinical study, paving the way for FDA submission by 2025.
Best Carbon Monoxide Detector for Your Home in 2025
Carbon monoxide can be a silent, odorless and invisible killer, but it can still be detected. Protect your family with these ...
AHA/ASA Journals5d
Myeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to Promote Heart Failure With Preserved Ejection Fraction
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
Envirotech Online7d
Cleaner, healthier and more productive solutions from Servomex
Servomex is helping chemical manufacturers reduce their environmental impact and enhance safety and productivity by ...
News-Medical.Net4d
Revolutionizing medical devices with pressure sensing
The value of pressure sensing in medical equipment was highlighted during the COVID-19 pandemic. Discover how new tools are revolutionizing the field.
Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates
Significant progress in HYLA blood sensor and INSPIRA ART core technologies RA'ANANA, Israel, March 11, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd.